Ana Eduardo, MD
Obstetrics & Gynecology · Austin, TXNPI 1205809654
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,000 of the $17,133 with a category attached, or 70.0%. Exeltis, USA Inc. accounts for 72.3% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2023 at $12,776 and has fallen 97.2% since, to $362 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $59.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$12K
- AbbVie$1K
- Mayne Pharma Commercial LLC$474
- Hologic Sales And Service, LLC$406
- Coopersurgical, Inc.$293
- Lupin Inc.$211
- plus $2K from 34 others
Across 17 payments — averaging $16,839 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$286K
What the payments were for
- Consulting fees$12,00070%
- Food & beverage$5,13330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 24 | $12,384 |
| AbbVie(2 entities) | 101 | $1,191 |
| Mayne Pharma Commercial LLC | 16 | $474 |
| Hologic Sales And Service, LLC | 14 | $406 |
| Coopersurgical, Inc. | 12 | $293 |
| Lupin Inc. | 12 | $211 |
| Bayer | 12 | $202 |
| Evofem Biosciences, Inc. | 8 | $172 |
| Astellas Pharma US Inc | 9 | $168 |
| Myovant Sciences Inc. | 12 | $145 |
| Axonics, Inc. | 2 | $136 |
| Intuitive Surgical | 3 | $134 |
| Agile Therapeutics, Inc. | 7 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $102 |
| Pfizer | 5 | $99 |
| Avion Pharmaceuticals | 6 | $95 |
| Conmed Corporation | 1 | $83 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Exact Sciences | 3 | $64 |
| Organon | 3 | $57 |
| Duchesnay USA Incorporated | 4 | $52 |
| Merck | 3 | $52 |
| Biogen | 2 | $40 |
| Shield Therapeutics Inc | 2 | $39 |
| Dysis Medical, Inc. | 1 | $35 |
| Millicent US Inc | 2 | $33 |
| Minerva Surgical, Inc | 2 | $29 |
| Gynesonics, Inc. | 1 | $28 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Boston Scientific | 1 | $25 |
| Baxter Healthcare | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Meditrina | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Aspira Women's Health Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,133 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 52 | $2,945 |
| DottiEstradiol | 12 | $1,432 |
| ProgesteroneProgesterone, Micronized | 36 | $1,384 |
| Ibandronate Sodium | 21 | $1,255 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.